Innovation Pharmaceuticals Inc. Business Finance Contracts & Agreements

Series A Preferred Share Purchase Agreement, dated June 9, 2022, by and among Squalus Med Ltd. and Innovation Pharmaceuticals Inc (Filed With SEC on June 15, 2022)

Securities Purchase Agreement, dated December 9, 2020, between the Company and the investor party thereto (Filed With SEC on December 10, 2020)

Form of Warrant (Filed With SEC on December 10, 2020)

Common Stock Purchase Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC (Filed With SEC on August 4, 2020)

Registration Rights Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC (Filed With SEC on August 4, 2020)

Form of Warrant Amendment Agreement, dated December 26, 2019, between the Company and each investor party thereto (Filed With SEC on December 26, 2019)

Description of Class A common stock (Filed With SEC on September 30, 2019)

Form of Warrant Restructuring and Additional Issuance Agreement, dated May 9, 2019, between the Company and the investors party thereto (Filed With SEC on May 10, 2019)

Form of Series 4 Warrant (Filed With SEC on May 10, 2019)

Securities Purchase Agreement, dated October 5, 2018, between the Company and the investors party thereto (Filed With SEC on October 9, 2018)

Form of Warrant (Filed With SEC on October 9, 2018)

Securities Purchase Agreement, dated June 28, 2018, between the Company and Aspire Capital Fund, LLC (Filed With SEC on June 29, 2018)

Form of Warrant (Filed With SEC on June 29, 2018)

Registration Rights Agreement, dated as of September 6, 2017 by and between the Company and Aspire Capital Fund, LLC (Filed With SEC on September 11, 2017)

Common Stock Purchase Agreement, dated as of September 6, 2017 by and between the Company and Aspire Capital Fund, LLC (Filed With SEC on September 11, 2017)

Form of Stock Purchase Agreement (Filed With SEC on March 31, 2017)

Form of Restricted Stock Award Agreement for Non-employee Directors (Filed With SEC on July 1, 2016)

Form of Restricted Stock Award Agreement for Employees (Filed With SEC on July 1, 2016)

Form of Non-qualified Stock Option Agreement for Non-employee Directors (Filed With SEC on July 1, 2016)

Form of Non-qualified Stock Option Agreement for Employees (Filed With SEC on July 1, 2016)

EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 31, 2015)

EXHIBIT 10.1 COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2015)

ASSIGNMENT (Filed With SEC on September 2, 2014)

FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on September 9, 2013)

ASSET PURCHASE AGREEMENT dated as of July 29, 2013 by and among JEOFFREY L. BURTCH, THE CHAPTER 7 TRUSTEE FOR THE ESTATES OF POLYMEDIX, INC. AND POLYMEDIX PHARMACEUTICALS, INC. as... (Filed With SEC on September 9, 2013)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 10, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 10, 2012)

CELLCEUTIX CORPORATION SUBSCRIPTION AGREEMENT Series A Convertible Shares REGULATION D Dated: May 8, 2012 SECTION 1 (Filed With SEC on May 10, 2012)

CELLCEUTIX CORPORATION SUBSCRIPTION AGREEMENT REGULATION D Dated:October 11,2011 SECTION 1 (Filed With SEC on October 13, 2011)

ADDENDUM TO EHRLICH DEMAND UNSECURED NOTE KNOWN AS EHRLICH PROMISSORY NOTE C IN THE AMOUNT OF $1,750,000.00 DATED AUGUST 25, 2010 (Filed With SEC on May 23, 2011)

AMENDED AND RESTATED GUARANTY (Filed With SEC on February 22, 2011)

AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on February 22, 2011)

GUARANTY (Filed With SEC on May 15, 2008)

COMPOUND ASSIGNMENT AGREEMENT (Filed With SEC on December 12, 2007)

Category

Industry

Companies

Contracts

Innovation Pharmaceuticals Inc. Business Finance Contracts & Agreements